Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp

Clinical trial NCT06954493 · COMPLETED

Trial details

NCT number: NCT06954493
Sponsor: Scynexis, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vulvovaginal Candidiasis Candida Infection Vaginal Candidiasis

Start date: 2023-07-12
Primary completion: 2023-11-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.